We are live on
!
Find out more
KCM
Kingdon Capital Management Portfolio holdings
AUM
$911M
1-Year Est. Return
51.11%
This Fund
S&P 500
This Quarter
Est. Return
+3.42%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$2.07B
AUM Growth
-$113M
(-5.2%)
Cap. Flow
-$164M
Cap. Flow
% of AUM
-7.94%
Top 10 Holdings %
Top 10 Hldgs %
31.22%
Holding
172
New
56
Increased
31
Reduced
28
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$62.2M |
| 2 |
Northern Trust
NTRS
|
+$29.5M |
| 3 |
Tyson Foods
TSN
|
+$28.2M |
| 4 |
Lincoln National
LNC
|
+$26.6M |
| 5 |
Meta Platforms (Facebook)
META
|
+$25.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newell Brands
NWL
|
+$69.9M |
| 2 |
Amazon
AMZN
|
+$56.7M |
| 3 |
CDK
CDK Global, Inc.
CDK
|
+$41.4M |
| 4 |
Herbalife
HLF
|
+$39.5M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$38.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.31% |
| 2 | Consumer Discretionary | 9.33% |
| 3 | Consumer Staples | 7.58% |
| 4 | Energy | 7.07% |
| 5 | Industrials | 7.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
CALL
Heron Therapeutics
HRTX
$96.8M
| $13.6M | 0.66% |
+1,035,000
| New | +$16.2M |
|
52
Southwest Airlines
LUV
$23B
| $12.9M | 0.62% |
+259,200
| New | +$11.6M |
|
|
GTYH
53
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
| $12.6M | 0.61% |
+1,200,000
| New | +$12.7M |
|
54
T-Mobile US
TMUS
$190B
| $12.1M | 0.58% |
209,845
-102,655
| -33% | -$5.37M |
|
55
CALL
Clorox
CLX
$11.9B
| $12M | 0.58% |
+100,000
| New | +$11.8M |
|
56
Nomad Foods
NOMD
$1.68B
| $11.9M | 0.57% |
1,240,090
-38,660
| -3% | -$422K |
|
57
CALL
State Street SPDR S&P Biotech ETF
XBI
$9.62B
| $11.8M | 0.57% |
+200,000
| New | +$12.3M |
|
|
PF
58
DELISTED
Pinnacle Foods, Inc.
PF
| $11.7M | 0.56% |
218,077
-395,149
| -64% | -$20M |
|
59
CALL
Eli Lilly
LLY
$1,000B
| $11.1M | 0.54% |
150,900
+50,100
| +50% | +$3.73M |
|
|
ETFC
60
DELISTED
E*Trade Financial Corporation
ETFC
| $10.7M | 0.52% |
+309,088
| New | +$9.86M |
|
|
SAGE
61
PUT
DELISTED
Sage Therapeutics
SAGE
| $10.2M | 0.49% |
+200,000
| New | +$9.43M |
|
62
Intercontinental Exchange
ICE
$85.2B
| $9.79M | 0.47% |
+173,500
| New | +$9.61M |
|
63
Voya Financial
VOYA
$9.07B
| $9.64M | 0.47% |
+245,700
| New | +$8.66M |
|
|
OTIC
64
DELISTED
Otonomy, Inc.
OTIC
| $9.62M | 0.47% |
604,860
+109,786
| +22% | +$1.84M |
|
|
SGYP
65
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $9.55M | 0.46% |
1,568,487
-69,923
| -4% | -$365K |
|
|
ATH
66
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $8.54M | 0.41% |
+192,308
| New | +$8.89M |
|
67
Church & Dwight Co
CHD
$23.7B
| $8.4M | 0.41% |
+190,000
| New | +$8.66M |
|
68
CALL
AstraZeneca
AZN
$245B
| $8.24M | 0.4% |
150,850
+125,000
| +484% | +$7.1M |
|
69
Travere Therapeutics
TVTX
$5.11B
| $7.83M | 0.38% |
413,591
+33,516
| +9% | +$685K |
|
|
ARAV
70
DELISTED
Aravive, Inc. Common Stock
ARAV
| $7.62M | 0.37% |
85,268
+5,092
| +6% | +$386K |
|
71
State Street Energy Select Sector SPDR ETF
XLE
$38.5B
| $7.53M | 0.36% |
+200,000
| New | +$7.23M |
|
72
Sinclair Inc
SBGI
$1B
| $7.53M | 0.36% |
225,671
-97,108
| -30% | -$2.89M |
|
|
73
State Street SPDR S&P Biotech ETF
XBI
$9.62B
| $7.4M | 0.36% |
+125,000
| New | +$7.72M |
|
74
Globe Life
GL
$14.3B
| $7.37M | 0.36% |
+99,934
| New | +$6.85M |
|
|
NOVN
75
DELISTED
Novan, Inc. Common Stock
NOVN
| $7.1M | 0.34% |
26,263
+6,469
| +33% | +$1.49M |
|
Similar funds
GC
ICP
NAM
SAA
GIG
SI
PAMI
BDP
Kingdon Capital Management's Q4 2016 Portfolio in Review
As of Q4 2016, Kingdon Capital Management held 172 positions worth $2.07B, down 5.2% from $2.18B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Kingdon Capital Management withdrew a net $164M in Q4 2016, closing 49 positions and reducing 28 holdings. Its most notable exit was CDK Global, Inc., an estimated $41.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
Against the trend, Kingdon Capital Management opened a new position in Union Pacific worth $65.6M.
- Kingdon Capital Management's largest Q4 2016 buy was Union Pacific: 632,510 shares worth $65.6M.
- Kingdon Capital Management added most to Tyson Foods in Q4 2016, an estimated $28.2M increase.
- Kingdon Capital Management's biggest Q4 2016 reduction was Newell Brands, cutting an estimated $69.9M.
- Kingdon Capital Management fully exited CDK Global, Inc. in Q4 2016, selling an estimated $41.4M.
- Kingdon Capital Management's ten largest holdings make up 31% of its $2.07B portfolio in Q4 2016.
- Kingdon Capital Management opened 56 new positions and closed 49 in Q4 2016.
- Kingdon Capital Management's portfolio value fell 5.2% quarter-over-quarter to $2.07B.
Based on Kingdon Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.